Vasoactive intestinal peptide binding autoantibodies in autoimmune humans and mice

Peptides

Volumn 23, Issue 12, 2002, Pages 2251-2257

  Bangale, Yogesh ^a   Cavill, Dana ^b   Gordon, Tom ^b   Planque, Stephanie ^a   Taguchi, Hiroaki ^a   Bhatia, Gita ^a   Nishiyama, Yasuhiro ^a   Arnett, Frank ^a   Paul, Sudhir ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Autoantibodies; Lupus; Neuroimmune interactions; Vasoactive intestinal peptide

Indexed keywords

AUTOANTIBODY; NEUROPEPTIDE; RECOMBINANT PROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; CROSS REACTION; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN ISOLATION; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; SERUM; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN FRAGMENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; RADIOIMMUNOASSAY; SCLERODERMA, SYSTEMIC; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0036948251     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00265-6     Document Type: Article

References (28)

1. Barry M.M., Lee J.S. Cloning and expression of an autoimmune DNA-binding single chain Fv: only the heavy chain is required for binding. Mol. Immunol. 30:1993;833-840.
2. Berisha H.I., Bratut M., Bangale Y., Colasurdo G., Paul S., Said S.I. New evidence for transmitter role of VIP in the airways: impaired relaxation by a catalytic antibody. Pulm. Pharmacol. Therap. 15:2002;121-127.
3. Bracci-Laudiero L., Aloe L., Stenfors C., Theodorsson E., Lundeberg T. Development of systemic lupus erythematosus in mice is associated with alteration of neuropeptide concentrations in inflamed kidneys and immunoregulatory organs. Neurosci. Lett. 248:1998;97-100.
4. Burastero S.E., Casali P., Wilder R.L., Notkins A.L. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J. Exp. Med. 168:1988;1979-1992.
5. Caughey G.H., Leidig F., Viro N.F., Nadel J.A. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J. Pharmacol. Exp. Ther. 244:1988;133-137.
6. Ciabattoni G., Montuschi P., Curro D., Togna G., Preziosi P. Effects of vasoactive intestinal peptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung. Br. J. Pharmacol. 109:1993;243-250.
7. Delgado M., Abad C., Martinez C., Leceta J., Gomariz R.P. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 7:2001;563-568.
8. Delgado M., Martinez C., Johnson M.C., Gomariz R.P., Ganea D. Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes. J. Neuroimmunol. 68:1996;27-38.
9. Dorsam G., Voice J., Kong Y., Goetzl E.J. Vasoactive intestinal peptide mediation of development and functions of T lymphocytes. Ann. NY. Acad. Sci. 921:2000;79-91.
10. Ganea D. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv. Neuroimmunol. 6:1996;61-74.
11. Gherardi E., Milstein C. Original and artificial antibodies. Nature. 357:1992;201-202.
12. Goetzl E.J., Voice J.K., Shen S., Dorsam G., Kong Y., West K.M.et al. Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide. Proc. Natl. Acad. Sci. U.S.A. 98:2001;13854-13859.
13. Hvidsten D., Jenssen T.G., Bolle R., Burhol P.G. Plasma gastrointestinal regulatory peptides in exercise-induced asthma. Eur. J. Respir. Dis. 68:1986;326-331.
14. Jabrane-Ferrat N., Bloom D., Wu A., Li L., Lo D., Sreedharan S.P.et al. Enhancement by vasoactive intestinal peptide of gamma-interferon production by antigen-stimulated type 1 helper T cells. FASEB J. 13:1999;347-353.
15. Kasaian M.T., Ikematsu H., Balow J.E., Casali P. Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus. J. Immunol. 152:1994;3137-3151.
16. Masi A.T., Rodnan G.P., Medsger T.A., Altman R.D., D'Angelo W.A., Fries J.F.et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23:1980;581-590.
17. Mody R.K., Tramontano A., Paul S. Spontaneous hydrolysis of vasoactive intestinal peptide in neutral aqueous solution. Int. J. Pept. Prot. Res. 44:1994;441-447.
18. Paul S., Li L., Kalaga R., O'Dell J., Dannenbring R.E., Swindells S.et al. Characterization of thyroglobulin-directed and polyreactive catalytic antibodies in autoimmune disease. J. Immunol. 159:1997;1530-1536.
19. Paul S., Said S.I. Human autoantibody to vasoactive intestinal peptide: increased incidence in muscular exercise. Life Sci. 43:1988;1079-1084.
20. Paul S., Said S.I., Thompson A.B., Volle D.J., Agrawal D.K., Foda H.et al. Characterization of autoantibodies to vasoactive intestinal peptide in asthma. J. Neuroimmunol. 23:1989;133-142.
21. Paul S., Sun M., Mody R., Eklund S.H., Beach C.M., Massey R.J.et al. Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies. J. Biol. Chem. 266:1991;16128-16134.
22. Paul S., Tramontano A., Gololobov G., Zhou Y.-X., Taguchi H., Karle S.et al. Phosphonate ester probes for proteolytic antibodies. J. Biol. Chem. 276:2001;28314-28320.
23. Said S.I. Influence of neuropeptides on airway smooth muscle. Am. Rev. Respir. Dis. 136:1987;S52-S58.
24. Sun M., Li L., Gao Q.S., Paul S. Antigen recognition by an antibody light chain. J. Biol. Chem. 269:1994;734-738.
25. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F.et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1982;1271-1277.
26. Theofilopoulos A.N. Genetics of systemic autoimmunity. J. Autoimmun. 9:1996;207-210.
27. Undem B.J., Dick E.C., Buckner C.K. Inhibition of vasoactive intestinal peptide of antigen-induced histamine release from guinea pig minced lung. J. Pharmacol. 88:1983;247-250.
28. Voice J.K., Dorsam G., Lee H., Kong Y., Goetzl E.J. Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor. FASEB J. 15:2001;2489-2496.